Sponsor pipeline

LG Chem clinical trial pipeline

Get alerts when LG Chem's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 2/3
1
Phase 4
2
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07710430 A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious… Central Precocious Puberty Recruiting 2026-07-29
NCT06921395 Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen… Female Infertility Active, Not Recruiting 2026-09-02
Phase 2/3
NCT06947499 A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of… Diphtheria Active, Not Recruiting 2026-09-03
Phase 1/2
NCT07752875 A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53… Ovarian Cancer Not Yet Recruiting 2026-08-07
Phase 1
NCT06332755 Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in… Non-small Cell Lung Cancer(NSCLC) Recruiting 2025-11-24
Not specified
NCT06206135 Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and… Hyperphosphatemia Recruiting 2026-09-03
NCT01604395 Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS… Growth Hormone Deficiency Recruiting 2021-02-21

Disease areas by active trials, top 10 of 15

Head & Neck Cancer (2) · Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Bladder Cancer (1) · Breast Cancer (1) · Chronic Kidney Disease (1) · Colorectal Cancer (1) · Endometrial Cancer (1) · Esophageal Cancer (1) · Heart Disease (1)

Get alerts when LG Chem's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free